Brie Carter

DEFSEC Technologies (NASDAQ:DFSC) reported preliminary cash and cash equivalents of approximately $7.7 million at September 30, 2026, more than doubling its June balance.

Cognizant (NASDAQ:CTSH) announced a five-year agreement with payment technology company Ingenico to modernize its global technology infrastructure, applications and data operations.

Oculis (NASDAQ:OCS) will present new Phase 2 ACUITY biomarker analyses of its investigational Privosegtor treatment on October 22, 2026, in Toronto.

Sophon has set 30 November 2026 for its mainnet shutdown, giving users until 25 November to withdraw their assets.

Beacon Lighting (ASX:BLX) shareholders cast an almost 21% protest vote against the company remuneration report at the annual general meeting.

SkyAI, Inc. (NASDAQ:SKYA) is offering US$3 per share or warrant, targeting up to 95% of each outstanding class.

PolyNovo (ASX:PNV) announced CFO Jan Gielen will step down after nearly eight years with the company to pursue a new opportunity.

Percheron Therapeutics (ASX:PER) has entered into a preclinical research collaboration with Invion (ASX:IVX) to evaluate its clinical-stage antibody HMBD-002.

Mastercard Incorporated (NYSE:MA) launched Stablecoin Security on 19 October, extending its fraud-detection capabilities to stablecoin payments.

Summit Therapeutics (NASDAQ:SMMT) announced the opening of a Phase 2 kidney cancer trial evaluating ivonescimab-based treatments in approximately 100 patients across two countries.